$12.68

-3.41 (-21.19%)

Weekly Expected Move ±11.9%

$10 $11 $13 $14 $16

NASDAQ · Healthcare · Medical - Devices · Tech Score Neutral · Power 45 · $986.2M mcap · 59M float · 1.52% daily turnover · Short 67% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE

41.8 / 100

NoneWeakNarrowWide

Primary source: Cost Advantage · ROIC: 18.4% · 5Y Avg: 2.2%

Cost Advantage ★

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. IART shows a Weak competitive edge (41.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 18.4% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$15

Low

$15

Avg Target

$15

High

Based on 1 analyst since Jul 29, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 11Hold: 11Sell: 4Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$18.00

Analysts4

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-10-03	Wells Fargo	Larry Biegelsen	$25	$15	-10	+18.3%	$12.68
2026-07-28	UBS	—	Initiated	$19	—	-2.7%	$19.53
2026-07-16	Truist Financial	—	$12	$19	+7	-3.8%	$19.75
2026-07-08	BMO Capital	—	Initiated	$19	—	+9.8%	$17.30
2026-06-18	Argus Research	—	Initiated	$25	—	+45.3%	$17.20
2026-04-15	Truist Financial	Richard Newitter	$15	$12	-3	+9.0%	$11.01
2025-10-15	Truist Financial	—	$26	$15	-11	+1.7%	$14.76
2024-10-07	BTIG	Ryan Zimmerman	$22	$20	-2	+14.7%	$17.43
2024-07-30	Truist Financial	Richard Newitter	$32	$26	-6	+5.7%	$24.59
2024-07-29	Citigroup	Joanne Wuensch	Initiated	$23	—	-9.5%	$25.42
2024-07-29	BTIG	Ryan Zimmerman	Initiated	$22	—	-13.5%	$25.42
2024-07-16	Truist Financial	Richard Newitter	$25	$32	+7	+7.2%	$29.84
2024-05-07	Truist Financial	Richard Newitter	Initiated	$25	—	+8.0%	$23.14
2024-05-07	JMP Securities	David Turkaly	Initiated	$40	—	+72.9%	$23.14
2024-05-06	Wells Fargo	Vik Chopra	$74	$25	-49	+8.0%	$23.14
2022-10-26	Piper Sandler	Matt O'Brien	$55	$50	-5	+6.7%	$46.85
2022-07-28	Piper Sandler	FY22 EPS	Initiated	$55	—	-2.7%	$56.53
2021-04-28	RBC Capital	Shagun Singh Chadha	Initiated	$74	—	-1.4%	$75.07
2021-04-28	Wells Fargo	Larry Biegelsen	Initiated	$74	—	-1.4%	$75.07

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+

Oct 02, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. IART receives an overall rating of C+. Strongest factors: DCF (5/5), P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).

Rating Change History

Date	From	To
2026-05-08	B-	C+
2026-05-05	C-	B-
2026-05-05	C+	C-
2026-02-27	C	C+
2026-02-26	C+	C
2026-01-03	B-	C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 32 Grade D

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. IART scores highest in Growth (69/100) and lowest in Profitability (19/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

1.33

Distress Zone

Piotroski F-Score

6/9

✗ ✓ ✓ ✓ ✗ ✓ ✗ ✓ ✓

Beneish M-Score

-2.70

Unlikely Manipulator

Ohlson O-Score

-6.60

Bankruptcy prob: 0.1%

Low Risk

Credit Rating

B+

Score: 31.6/100

Trend: Improving

Earnings Quality

—

OCF/NI: -11.78x

Accruals: -2.6%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. IART scores 1.33, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. IART scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. IART's score of -2.70 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. IART's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. IART receives an estimated rating of B+ (score: 31.6/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

-137.53x

PEG

-1.37x

P/S

0.60x

P/B

0.94x

P/FCF

36.22x

P/OCF

16.45x

EV/EBITDA

12.74x

EV/Revenue

1.92x

EV/EBIT

32.99x

EV/FCF

81.78x

Earnings Yield

-0.52%

FCF Yield

2.76%

Shareholder Yield

0.00%

Graham Number

—

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. IART currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

40.464

NI / EBT

Interest Burden

-0.002

EBT / EBIT

EBIT Margin

0.058

EBIT / Rev

Asset Turnover

0.454

Rev / Assets

Equity Multiplier

3.472

Assets / Equity

ROE

-0.7%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. IART's ROE of -0.7% is driven by financial leverage (equity multiplier: 3.47x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 40.46 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

—

Price/Value

—

Margin of Safety

—

Premium

—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$12.68

Median 1Y

$9.14

5th Pctile

$4.20

95th Pctile

$19.88

Ann. Volatility

46.1%

Analyst Target

$18.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Mojdeh Poul President and Chief Executive Officer and Director	$1,009,616	$5,219,868	$9,375,551
Lea Knight Financial Vice President and Chief Financial Officer	$638,646	$1,498,719	$2,882,994
Michael J. McBreen Executive Vice President, President, Codman Specialty Surgical	$643,750	$1,327,764	$2,713,278
Robert T. Davis, Jr Executive Vice President, President, Tissue Technologies	$583,354	$892,712	$1,912,633
Harvinder Singh President, Vice President, President, International	$563,993	$683,126	$1,625,444
Jan De Witte Former President and Chief Executive Officer and Director	$42,308	$—	$282,679

CEO Pay Ratio

59:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $9,375,551

Avg Employee Cost (SGA/emp): $158,053

Employees: 4,427

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

4,427

+0.7% YoY

Revenue / Employee

$369,380

Rev: $1,635,245,000

Profit / Employee

$-116,665

NI: $-516,474,000

SGA / Employee

$158,053

Avg labor cost proxy

R&D / Employee

$22,356

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	14.3%	10.6%	10.0%	10.3%	10.3%	10.3%	10.4%	7.9%	6.1%	4.0%	2.5%	1.5%	-0.4%	-0.4%	-1.9%	-38.9%	-38.7%	-39.9%	-38.6%	-0.7%	-0.69%
ROA	6.0%	4.6%	4.2%	4.5%	4.6%	4.7%	4.6%	3.5%	2.7%	1.8%	1.0%	0.6%	-0.2%	-0.2%	-0.7%	-12.9%	-12.8%	-13.5%	-13.0%	-0.2%	-0.20%
ROIC	7.3%	5.5%	6.2%	6.4%	6.7%	6.8%	6.5%	5.1%	4.1%	3.1%	2.3%	1.7%	0.7%	0.7%	0.2%	-14.1%	-12.9%	1.9%	3.5%	18.4%	18.40%
ROCE	7.0%	7.0%	6.4%	6.5%	6.8%	7.2%	7.3%	6.0%	4.9%	3.8%	2.6%	2.3%	1.7%	1.7%	1.0%	-17.6%	-14.1%	-15.2%	-13.7%	3.0%	2.97%
Gross Margin	62.7%	61.5%	62.1%	62.7%	61.5%	62.8%	61.1%	54.3%	57.1%	57.0%	56.1%	54.0%	52.6%	56.3%	50.8%	50.4%	56.2%	49.5%	57.2%	52.5%	52.47%
Operating Margin	14.6%	14.4%	12.3%	15.0%	16.9%	17.0%	9.6%	3.3%	7.0%	9.1%	1.1%	-0.7%	-2.1%	8.0%	-4.0%	-1.2%	10.0%	1.3%	10.2%	4.6%	4.61%
Net Margin	11.2%	11.2%	8.7%	11.3%	13.0%	13.3%	6.4%	1.1%	5.1%	5.0%	-0.9%	-3.0%	-2.8%	4.4%	-6.6%	-1.2%	-1.3%	-0.4%	-1.2%	1.1%	1.07%
EBITDA Margin	22.8%	22.2%	20.0%	23.8%	26.7%	26.2%	19.5%	12.4%	16.3%	18.5%	10.6%	9.6%	9.2%	17.9%	6.8%	-1.1%	13.4%	15.2%	16.0%	15.7%	15.73%
FCF Margin	19.3%	17.1%	14.9%	13.1%	12.0%	14.0%	12.8%	10.0%	7.1%	4.7%	4.0%	3.8%	2.4%	0.9%	-1.6%	-2.9%	-0.9%	-2.8%	-0.6%	2.4%	2.35%
OCF Margin	21.2%	20.3%	18.5%	16.8%	15.9%	17.0%	15.8%	13.5%	10.8%	9.1%	8.5%	9.0%	8.8%	8.0%	6.3%	4.4%	5.4%	3.1%	4.3%	5.2%	5.18%
ROE 3Y Avg	snapshot only																				-15.78%
ROE 5Y Avg	snapshot only																				-5.91%
ROA 3Y Avg	snapshot only																				-4.42%
ROIC 3Y Avg	snapshot only																				1.60%
ROIC Economic	snapshot only																				16.95%
Cash ROA	snapshot only																				2.38%
Cash ROIC	snapshot only																				3.03%
CROIC	snapshot only																				1.38%
NOPAT Margin	snapshot only																				31.45%
Pretax Margin	snapshot only																				-0.01%
R&D / Revenue	snapshot only																				5.77%
SGA / Revenue	snapshot only																				41.82%
SBC / Revenue	snapshot only																				0.69%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	27.04	33.99	34.59	27.17	20.42	25.98	27.50	25.43	30.22	50.36	68.49	95.39	-212.26	-251.56	-58.07	-1.87	-2.22	-1.85	-1.46	-193.83	-137.527
P/S Ratio	3.84	3.73	3.47	2.88	2.26	3.01	3.03	2.16	1.98	2.21	1.80	1.44	0.89	1.08	1.04	0.58	0.67	0.58	0.44	0.85	0.599
P/B Ratio	3.59	3.41	3.35	2.72	2.05	2.60	2.82	1.98	1.93	2.15	1.72	1.47	0.91	1.13	1.10	0.90	1.06	0.91	0.70	1.34	0.943
P/FCF	19.88	21.73	23.32	22.07	18.76	21.58	23.68	21.50	27.77	46.67	45.23	38.30	36.52	116.35	-66.05	-19.80	-76.03	-21.06	-71.61	36.22	36.225
P/OCF	18.09	18.39	18.82	17.19	14.22	17.74	19.19	16.04	18.30	24.37	21.27	15.92	10.11	13.50	16.43	13.24	12.32	18.92	10.15	16.45	16.453
EV/EBITDA	19.64	18.84	19.83	16.64	13.09	15.55	16.04	14.11	15.51	18.60	18.63	18.45	16.51	17.89	19.01	-8.12	-9.06	-8.35	-8.64	12.74	12.739
EV/Revenue	4.62	4.47	4.28	3.70	3.03	3.76	3.86	3.00	2.89	3.10	2.70	2.53	1.98	2.15	2.11	1.66	1.73	1.67	1.52	1.92	1.923
EV/EBIT	29.31	28.43	31.19	25.71	19.82	22.92	23.94	22.66	27.14	36.12	41.78	46.07	57.98	65.99	104.54	-5.61	-6.12	-5.71	-5.66	32.99	32.993
EV/FCF	23.94	26.09	28.72	28.33	25.21	26.97	30.22	29.84	40.67	65.45	67.87	67.38	81.52	230.34	-134.62	-56.95	-196.16	-60.17	-246.87	81.78	81.777
Earnings Yield	3.7%	2.9%	2.9%	3.7%	4.9%	3.8%	3.6%	3.9%	3.3%	2.0%	1.5%	1.0%	-0.5%	-0.4%	-1.7%	-53.4%	-45.0%	-54.2%	-68.4%	-0.5%	-0.52%
FCF Yield	5.0%	4.6%	4.3%	4.5%	5.3%	4.6%	4.2%	4.7%	3.6%	2.1%	2.2%	2.6%	2.7%	0.9%	-1.5%	-5.0%	-1.3%	-4.7%	-1.4%	2.8%	2.76%
EV/OCF	snapshot only																				37.143
EV/Gross Profit	snapshot only																				3.579
Acquirers Multiple	snapshot only																				4.832
Shareholder Yield	snapshot only																				0.00%

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	3.32	3.39	3.38	3.85	3.93	3.62	3.65	2.78	2.89	3.45	4.68	3.39	1.20	1.17	1.21	1.23	3.14	2.54	3.38	3.40	3.403
Quick Ratio	2.33	2.46	2.34	2.76	2.91	2.61	2.40	1.85	1.86	2.18	3.35	2.10	0.73	0.71	0.72	0.73	1.80	1.46	1.95	1.98	1.985
Debt/Equity	1.02	0.99	1.03	1.04	1.00	0.90	0.96	0.95	1.07	1.06	1.28	1.31	1.31	1.28	1.32	1.94	1.93	1.95	1.96	1.94	1.941
Net Debt/Equity	0.73	0.68	0.78	0.77	0.71	0.65	0.78	0.77	0.90	0.86	0.86	1.12	1.13	1.11	1.15	1.69	1.68	1.70	1.70	1.68	1.680
Debt/Assets	0.44	0.44	0.45	0.46	0.45	0.42	0.43	0.42	0.45	0.44	0.50	0.49	0.49	0.49	0.50	0.55	0.55	0.56	0.57	0.57	0.569
Debt/EBITDA	4.64	4.55	4.94	4.96	4.76	4.32	4.29	4.88	5.87	6.54	9.20	9.35	10.60	10.27	11.20	-6.06	-6.41	-6.23	-7.05	8.20	8.197
Net Debt/EBITDA	3.33	3.15	3.73	3.68	3.35	3.11	3.47	3.94	4.92	5.34	6.22	7.96	9.12	8.85	9.68	-5.30	-5.55	-5.42	-6.13	7.10	7.096
Interest Coverage	4.32	4.82	4.35	4.68	4.91	5.16	5.03	4.07	3.26	2.58	1.87	1.46	0.82	0.74	0.42	-6.03	-5.59	-5.44	-4.68	1.00	0.998
Equity Multiplier	2.31	2.24	2.27	2.26	2.21	2.16	2.23	2.24	2.37	2.38	2.55	2.66	2.67	2.61	2.66	3.53	3.51	3.45	3.43	3.41	3.413
Cash Ratio	snapshot only																				0.790
Debt Service Coverage	snapshot only																				2.585
Cash to Debt	snapshot only																				0.134
FCF to Debt	snapshot only																				0.019
Defensive Interval	snapshot only																				860.5 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.42	0.42	0.42	0.42	0.41	0.41	0.42	0.41	0.41	0.40	0.39	0.40	0.40	0.41	0.40	0.42	0.43	0.43	0.43	0.45	0.454
Inventory Turnover	1.85	1.91	1.81	1.84	1.87	1.83	1.75	1.83	1.87	1.84	1.78	1.78	1.76	1.78	1.78	1.73	1.65	1.71	1.64	1.59	1.593
Receivables Turnover	6.82	6.74	6.81	6.71	6.65	6.29	6.27	6.23	5.99	5.90	6.06	5.84	6.08	6.06	6.58	5.77	6.44	5.93	6.36	5.97	5.973
Payables Turnover	10.72	10.27	7.93	8.77	8.49	7.17	5.89	7.31	7.28	6.76	6.48	6.65	8.24	8.33	8.13	7.67	8.99	8.87	8.59	8.43	8.432
DSO	53	54	54	54	55	58	58	59	61	62	60	62	60	60	55	63	57	62	57	61	61.1 days
DIO	197	192	201	199	196	199	209	199	195	198	205	206	208	205	205	211	221	213	223	229	229.2 days
DPO	34	36	46	42	43	51	62	50	50	54	56	55	44	44	45	48	41	41	43	43	43.3 days
Cash Conversion Cycle	216	210	209	211	207	207	205	208	206	206	209	213	224	222	216	226	237	233	238	247	247.0 days
Fixed Asset Turnover	snapshot only																				2.821
Operating Cycle	snapshot only																				290.3 days
Cash Velocity	snapshot only																				6.012
Capital Intensity	snapshot only																				2.176

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	10.7%	12.4%	13.2%	3.8%	2.6%	1.0%	0.2%	-1.4%	-1.4%	-1.0%	-2.1%	1.4%	1.4%	4.5%	6.2%	3.5%	5.0%	1.5%	1.2%	1.6%	1.60%
Net Income	2.8%	26.3%	-8.0%	-19.1%	-20.1%	6.8%	9.8%	-21.1%	-41.7%	-62.5%	-76.6%	-82.0%	-1.1%	-1.1%	-1.7%	-22.2%	-74.7%	-73.4%	-16.1%	98.6%	98.55%
EPS	2.8%	25.0%	-6.9%	-17.4%	-18.1%	9.5%	12.4%	-18.7%	-39.1%	-59.9%	-75.2%	-81.1%	-1.1%	-1.1%	-1.7%	-22.4%	-74.4%	-73.6%	-16.0%	98.6%	98.58%
FCF	89.8%	65.3%	4.1%	-27.4%	-36.0%	-17.8%	-14.1%	-24.2%	-41.7%	-66.4%	-69.5%	-62.1%	-65.3%	-79.5%	-1.4%	-1.8%	-1.4%	-4.0%	60.2%	1.8%	1.82%
EBITDA	34.7%	30.3%	2.6%	-4.3%	1.1%	3.0%	11.7%	-5.8%	-20.7%	-31.8%	-41.0%	-34.5%	-34.7%	-24.9%	-18.7%	-2.5%	-2.7%	-2.7%	-2.6%	1.7%	1.75%
Op. Income	42.2%	30.3%	37.2%	14.5%	19.6%	21.1%	7.7%	-17.6%	-37.5%	-53.3%	-65.5%	-65.0%	-79.9%	-74.5%	-88.7%	-8.9%	-16.7%	1.4%	12.8%	2.3%	2.31%
OCF Growth	snapshot only																				20.37%
Asset Growth	snapshot only																				-2.23%
Equity Growth	snapshot only																				1.16%
Debt Growth	snapshot only																				1.28%
Shares Change	snapshot only																				2.23%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	1.5%	1.6%	1.9%	1.6%	1.3%	0.9%	1.1%	3.7%	3.8%	4.0%	3.5%	1.3%	0.9%	1.5%	1.4%	1.2%	1.6%	1.6%	1.7%	2.2%	2.16%
Revenue 5Y	9.3%	9.2%	9.0%	8.4%	7.8%	5.6%	4.0%	2.4%	1.1%	0.9%	0.7%	1.0%	0.8%	1.2%	1.4%	3.2%	3.6%	3.6%	3.6%	1.8%	1.77%
EPS 3Y	39.8%	41.1%	24.7%	19.3%	43.6%	55.1%	88.9%	—	23.8%	-18.1%	-36.2%	-49.8%	—	—	—	—	—	—	—	—	—
EPS 5Y	28.1%	16.8%	16.6%	19.1%	27.6%	21.6%	19.2%	14.1%	6.4%	4.3%	-11.6%	-23.6%	—	—	—	—	—	—	—	—	—
Net Income 3Y	39.3%	40.6%	23.8%	18.1%	42.3%	53.2%	86.2%	—	21.3%	-20.3%	-38.2%	-51.4%	—	—	—	—	—	—	—	—	—
Net Income 5Y	29.5%	18.4%	18.3%	20.4%	28.9%	22.8%	19.9%	13.4%	4.7%	2.2%	-13.4%	-25.2%	—	—	—	—	—	—	—	—	—
EBITDA 3Y	1.6%	2.0%	1.0%	4.9%	20.4%	26.8%	28.2%	25.8%	2.6%	-2.9%	-12.2%	-16.1%	-19.4%	-19.2%	-18.8%	—	—	—	—	-8.8%	-8.82%
EBITDA 5Y	10.0%	10.2%	8.1%	8.1%	8.6%	7.1%	4.8%	0.5%	-3.4%	-5.7%	-7.4%	-6.6%	-2.0%	0.9%	0.2%	—	—	—	—	-7.3%	-7.32%
Gross Profit 3Y	1.9%	1.6%	1.6%	1.6%	0.9%	0.6%	0.9%	2.7%	2.0%	1.3%	0.6%	-1.9%	-2.8%	-2.3%	-3.4%	-4.4%	-3.2%	-4.5%	-3.3%	-1.5%	-1.51%
Gross Profit 5Y	8.5%	8.0%	7.8%	7.3%	6.7%	5.2%	4.1%	2.0%	0.5%	-0.4%	-1.3%	-1.2%	-1.9%	-1.5%	-1.6%	-0.1%	0.6%	-0.1%	0.7%	-1.0%	-0.98%
Op. Income 3Y	31.6%	21.1%	21.8%	17.5%	35.7%	36.6%	37.3%	47.5%	2.1%	-9.7%	-20.1%	-30.9%	-46.8%	-47.6%	-65.2%	—	—	-34.1%	-18.5%	53.4%	53.38%
Op. Income 5Y	14.2%	11.3%	15.6%	17.7%	24.0%	39.8%	30.6%	20.7%	11.2%	0.1%	-7.6%	-14.1%	-20.7%	-21.2%	-36.8%	—	—	-14.7%	-4.4%	27.7%	27.75%
FCF 3Y	42.0%	29.4%	28.6%	10.1%	58.9%	30.9%	34.1%	47.5%	-10.9%	-23.0%	-35.1%	-40.7%	-49.4%	-61.6%	—	—	—	—	—	-37.0%	-37.03%
FCF 5Y	25.1%	30.8%	23.6%	27.4%	26.3%	25.1%	20.8%	14.9%	1.3%	-9.7%	-11.0%	-17.4%	-4.1%	-31.1%	—	—	—	—	—	-32.8%	-32.75%
OCF 3Y	24.3%	16.1%	15.3%	4.6%	10.3%	4.5%	3.4%	5.4%	-7.8%	-11.8%	-19.9%	-23.0%	-24.8%	-25.5%	-29.1%	-35.4%	-28.9%	-42.5%	-33.8%	-25.7%	-25.71%
OCF 5Y	19.0%	21.8%	17.9%	18.8%	17.8%	18.2%	14.1%	9.1%	-0.2%	-6.9%	-7.1%	-9.2%	-5.8%	-11.0%	-14.4%	-16.8%	-15.9%	-24.4%	-22.3%	-22.8%	-22.76%
Assets 3Y	5.9%	6.8%	4.6%	4.5%	4.4%	5.6%	2.8%	3.7%	2.7%	1.5%	2.9%	3.1%	2.5%	2.2%	3.3%	-0.8%	-1.4%	-2.5%	-1.5%	-1.7%	-1.72%
Assets 5Y	15.6%	15.9%	12.4%	12.3%	9.5%	3.9%	2.9%	3.5%	3.3%	4.0%	4.9%	4.4%	4.0%	4.1%	3.3%	1.6%	1.1%	-0.1%	-0.9%	-0.7%	-0.69%
Equity 3Y	6.1%	7.0%	5.0%	5.3%	7.6%	8.4%	7.7%	7.7%	4.1%	1.6%	1.5%	-0.9%	-2.3%	-2.8%	-1.9%	-14.5%	-15.6%	-16.7%	-14.6%	-14.5%	-14.53%
Book Value 3Y	6.5%	7.4%	5.8%	6.4%	8.6%	9.7%	9.2%	9.2%	6.3%	4.4%	4.6%	2.4%	1.4%	0.7%	1.3%	-11.9%	-13.2%	-14.3%	-12.7%	-13.5%	-13.46%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.66	0.64	0.66	0.78	0.75	0.70	0.67	0.82	0.45	0.34	0.29	0.76	0.74	0.69	0.53	0.82	0.85	0.90	0.89	0.95	0.949
Earnings Stability	0.43	0.57	0.44	0.33	0.60	0.82	0.58	0.27	0.24	0.18	0.03	0.00	0.03	0.12	0.16	0.40	0.52	0.62	0.70	0.42	0.425
Margin Stability	0.98	0.98	0.97	0.97	0.98	0.99	0.99	0.99	0.98	0.97	0.96	0.96	0.95	0.94	0.93	0.93	0.93	0.92	0.93	0.93	0.931
Rev. Growth Consistency	0.50	0.50	0.50	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.50	1.00	0.00	0.00	0.00	1.00	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.500
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0	0	0	0	0	0	0
Earnings Persistence	0.50	0.89	0.97	0.50	0.92	0.97	0.96	0.92	0.83	0.50	0.50	0.50	0.20	0.20	0.20	0.20	0.50	0.50	0.50	0.50	0.500
Earnings Smoothness	0.00	0.77	0.92	0.79	0.78	0.93	0.91	0.76	0.47	0.09	0.00	0.00	—	—	—	—	—	—	—	—	—
ROE Trend	0.09	0.04	0.03	0.04	0.01	0.01	-0.00	-0.04	-0.05	-0.06	-0.07	-0.07	-0.09	-0.08	-0.08	-0.53	-0.51	-0.51	-0.48	0.23	0.226
Gross Margin Trend	-0.01	-0.01	0.00	0.01	0.00	0.01	0.00	-0.02	-0.03	-0.04	-0.06	-0.05	-0.05	-0.05	-0.06	-0.05	-0.03	-0.04	-0.02	-0.01	-0.006
FCF Margin Trend	0.12	0.08	0.04	0.02	-0.03	-0.00	-0.03	-0.06	-0.09	-0.11	-0.10	-0.08	-0.07	-0.08	-0.10	-0.10	-0.06	-0.06	-0.02	0.02	0.019
Sustainable Growth Rate	14.3%	10.6%	10.0%	10.3%	10.3%	10.3%	10.4%	7.9%	6.1%	4.0%	2.5%	1.5%	—	—	—	—	—	—	—	—	—
Internal Growth Rate	6.4%	4.8%	4.4%	4.7%	4.8%	4.9%	4.9%	3.6%	2.7%	1.8%	1.0%	0.6%	—	—	—	—	—	—	—	—	—

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	1.49	1.85	1.84	1.58	1.44	1.46	1.43	1.59	1.65	2.07	3.22	5.99	-21.00	-18.63	-3.54	-0.14	-0.18	-0.10	-0.14	-11.78	-11.781
FCF/OCF	0.91	0.85	0.81	0.78	0.76	0.82	0.81	0.75	0.66	0.52	0.47	0.42	0.28	0.12	-0.25	-0.67	-0.16	-0.90	-0.14	0.45	0.454
FCF/Net Income	snapshot only																				-5.351
OCF/EBITDA	snapshot only																				0.343
CapEx/Revenue	1.9%	3.1%	3.6%	3.7%	3.8%	3.0%	3.0%	3.4%	3.7%	4.3%	4.5%	5.3%	6.3%	7.1%	7.9%	7.3%	6.3%	5.8%	5.0%	2.8%	2.83%
CapEx/Depreciation	snapshot only																				0.305
Accruals Ratio	-0.03	-0.04	-0.04	-0.03	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.03	-0.04	-0.03	-0.03	-0.15	-0.15	-0.15	-0.15	-0.03	-0.026
Sloan Accruals	snapshot only																				0.129
Cash Flow Adequacy	snapshot only																				1.832

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—	—	—	—	—	—	—	—
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—	—	—	—	0.0%	0.00%
Total Payout Ratio	0.0%	0.3%	80.2%	75.5%	72.6%	69.4%	87.4%	1.1%	2.7%	4.1%	3.1%	7.4%	—	—	—	—	—	—	—	—	—
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	2.3%	2.8%	3.6%	2.7%	3.2%	4.5%	9.0%	8.1%	4.5%	7.8%	3.6%	3.0%	3.1%	0.3%	0.2%	0.0%	0.0%	0.0%	0.00%
Net Buyback Yield	-0.1%	-0.1%	2.2%	2.7%	3.5%	2.7%	3.2%	4.5%	9.0%	8.0%	4.3%	7.5%	3.2%	2.6%	3.1%	0.2%	0.2%	-0.1%	-0.1%	0.0%	0.00%
Total Shareholder Return	-0.1%	-0.1%	2.2%	2.7%	3.5%	2.7%	3.2%	4.5%	9.0%	8.0%	4.3%	7.5%	3.2%	2.6%	3.1%	0.2%	0.2%	-0.1%	-0.1%	0.0%	0.00%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	1.07	0.79	0.84	0.86	0.86	0.84	0.84	0.84	0.87	0.84	0.87	0.87	0.55	0.38	0.67	0.90	0.91	0.92	0.93	40.46	40.464
Interest Burden (EBT/EBIT)	0.84	0.88	0.87	0.86	0.84	0.84	0.81	0.77	0.71	0.61	0.47	0.31	-0.22	-0.35	-1.31	1.16	1.18	1.18	1.21	-0.00	-0.002
EBIT Margin	0.16	0.16	0.14	0.14	0.15	0.16	0.16	0.13	0.11	0.09	0.06	0.05	0.03	0.03	0.02	-0.30	-0.28	-0.29	-0.27	0.06	0.058
Asset Turnover	0.42	0.42	0.42	0.42	0.41	0.41	0.42	0.41	0.41	0.40	0.39	0.40	0.40	0.41	0.40	0.42	0.43	0.43	0.43	0.45	0.454
Equity Multiplier	2.39	2.31	2.36	2.31	2.26	2.20	2.25	2.25	2.28	2.26	2.39	2.44	2.52	2.50	2.60	3.01	3.01	2.95	2.97	3.47	3.472

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$2.53	$1.97	$1.86	$1.99	$2.07	$2.16	$2.09	$1.62	$1.26	$0.86	$0.52	$0.31	$-0.09	$-0.09	$-0.38	$-6.55	$-6.45	$-6.73	$-6.44	$-0.09	$-0.09
Book Value/Share	$19.10	$19.64	$19.17	$19.86	$20.68	$21.57	$20.35	$20.74	$19.79	$20.27	$20.56	$19.82	$19.90	$20.07	$19.93	$13.58	$13.52	$13.60	$13.55	$13.44	$13.44
Tangible Book/Share	$-6.28	$-5.53	$-6.12	$-4.92	$-3.69	$-4.32	$-5.78	$-5.59	$-6.56	$-6.84	$-5.98	$-10.21	$-10.52	$-9.86	$-10.05	$-10.02	$-9.61	$-9.20	$-8.79	$-8.54	$-8.54
Revenue/Share	$17.85	$17.98	$18.50	$18.74	$18.77	$18.62	$18.97	$19.04	$19.33	$19.68	$19.68	$20.24	$20.47	$20.91	$21.24	$21.21	$21.41	$21.31	$21.37	$21.08	$21.08
FCF/Share	$3.45	$3.08	$2.76	$2.45	$2.26	$2.60	$2.42	$1.91	$1.38	$0.93	$0.78	$0.76	$0.50	$0.19	$-0.33	$-0.62	$-0.19	$-0.59	$-0.13	$0.50	$0.50
OCF/Share	$3.78	$3.64	$3.41	$3.14	$2.98	$3.16	$2.99	$2.56	$2.09	$1.79	$1.67	$1.83	$1.80	$1.68	$1.34	$0.93	$1.16	$0.66	$0.93	$1.09	$1.09
Cash/Share	$5.50	$5.99	$4.83	$5.35	$6.14	$5.46	$3.73	$3.81	$3.43	$3.95	$8.53	$3.84	$3.63	$3.55	$3.57	$3.32	$3.49	$3.44	$3.45	$3.51	$3.51
EBITDA/Share	$4.20	$4.27	$3.99	$4.17	$4.35	$4.51	$4.57	$4.04	$3.61	$3.28	$2.85	$2.78	$2.46	$2.51	$2.36	$-4.34	$-4.08	$-4.25	$-3.76	$3.18	$3.18
Debt/Share	$19.50	$19.42	$19.74	$20.67	$20.72	$19.48	$19.57	$19.76	$21.17	$21.47	$26.27	$25.96	$26.02	$25.77	$26.40	$26.34	$26.13	$26.49	$26.50	$26.09	$26.09
Net Debt/Share	$13.99	$13.44	$14.91	$15.32	$14.58	$14.03	$15.84	$15.95	$17.74	$17.52	$17.74	$22.12	$22.39	$22.22	$22.83	$23.02	$22.64	$23.05	$23.05	$22.58	$22.58

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	1.326
Altman Z-Prime	snapshot only																				2.674
Piotroski F-Score	6	7	8	7	6	8	7	5	5	5	5	5	3	4	5	4	5	5	5	6	6
Beneish M-Score	-2.55	-2.58	-2.64	-2.60	-2.46	-2.45	-2.45	-2.40	-2.46	-2.55	-2.64	-2.54	-2.65	-2.55	-2.50	-3.22	-3.28	-3.21	-3.33	-2.70	-2.696
Ohlson O-Score	snapshot only																				-6.599
Net-Net WC	snapshot only																				$-17.33
EVA	snapshot only																				$236517620.00

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				B+
Credit Score	58.74	60.19	61.28	57.20	57.39	69.54	67.76	55.81	53.69	50.66	40.35	36.68	19.59	22.92	18.61	24.22	32.80	31.63	33.14	31.57	31.573
Credit Grade	snapshot only																				14
Credit Trend	snapshot only																				7.357
Implied Spread (bps)	snapshot only																				650.000
Industry Credit Rank	snapshot only																				26
Sector Credit Rank	snapshot only																				22

IART NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet